176 related articles for article (PubMed ID: 14689192)
21. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
22. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
23. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
24. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
25. [Current debate on hormone replacement therapy].
Georges B; Hermelink K; Untch M; Hepp H
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):63-8. PubMed ID: 15073435
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
27. A decade post WHI, menopausal hormone therapy comes full circle--need for independent commission.
Utian WH
Climacteric; 2012 Aug; 15(4):320-5. PubMed ID: 22762439
[TBL] [Abstract][Full Text] [Related]
28. The evidence base for HRT: what can we believe?
Langer RD
Climacteric; 2017 Apr; 20(2):91-96. PubMed ID: 28281363
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy: the perspectives for the 21st century.
Genazzani AR; Gambacciani M
Maturitas; 1999 May; 32(1):11-7. PubMed ID: 10423711
[TBL] [Abstract][Full Text] [Related]
30. [Current role of hormone replacement therapy in the prevention of postmenopausal osteoporosis: gynecologic point of view].
Tamborini A; Ruiz JC
Rev Med Interne; 2004 Dec; 25 Suppl 5():S580-7. PubMed ID: 15841951
[TBL] [Abstract][Full Text] [Related]
31. [Estrogen therapy in climacteric. Current views in an evidence-based perspective].
Nilsson K
Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812
[TBL] [Abstract][Full Text] [Related]
32. [Risks, benefits and costs of hormone replacement therapy in menopause].
Gaspard U
Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
[TBL] [Abstract][Full Text] [Related]
33. [Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
Wirthner D; Cornuz J; Lamy O
Praxis (Bern 1994); 2004 Feb; 93(9):315-20. PubMed ID: 15060972
[TBL] [Abstract][Full Text] [Related]
34. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Magnusson C; Weiderpass E
Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
[TBL] [Abstract][Full Text] [Related]
35. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
36. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
37. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
38. Current perspectives on benefits and risks of hormone replacement therapy.
Burkman RT; Collins JA; Greene RA
Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S13-23. PubMed ID: 11521118
[TBL] [Abstract][Full Text] [Related]
39. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement therapy in peri- and postmenopausal women and breast cancer risk].
Buchholz S; Horn F; Ortmann O
Ther Umsch; 2008 Apr; 65(4):231-4. PubMed ID: 18622916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
